Transfer Partners advised the sole shareholder of Berlin-based Alphalytik Pharmaservice GmbH on the sale of its shares to Certania Holding GmbH, Munich.

Founded in 1995 as a laboratory for pharmaceutical analysis, the company acts as an external service provider (CRO) for the analysis of drugs and pharmaceutical substances, in particular for method development and validation for active pharmaceutical ingredients and dosage forms, release testing and stability testing. Alphalytik has excellent expertise in special topics in pharmaceutical analysis, e.g. in the area of low-dose or low-soluble substances.

The company will continue to operate as an independent company within the Certania Group, all employees will be taken on and all current and planned projects will be continued in the usual high quality under the new shareholder.

Transfer Partners' mandate encompassed the entire M&A process, including the preparation of transaction-related documents, the identification and approach of selected candidates, managing the due diligence, and support in negotiations to ensure a successful signing and closing.